Neoplasm Treatment - United Arab Emirates
United Arab Emirates- The Neoplasm Treatment market in the United Arab Emirates is expected to experience significant growth in the coming years.
- By 2024, the projected revenue is estimated to reach US$1.09bn.
- This growth is predicted to continue with an annual growth rate (CAGR 2024-2029) of 6.62%, resulting in a market volume of US$1.50bn by 2029.
- When compared globally, in the United Arab Emirates is anticipated to generate significant revenue.
- However, it is worth noting that United States is expected to lead in terms of revenue generation, with a projected revenue of US$90.56bn in 2024.
- With the increasing investment in advanced medical technologies and the establishment of specialized cancer treatment centers, the United Arab Emirates is becoming a hub for innovative neoplasm treatment.
Definition:
Neoplasm Treatment refers to the medical and surgical treatments of cancer patients who require hospitalization for their care. This includes surgeries, chemotherapy, radiation therapy, immunotherapy, and/or other treatments that require close monitoring and support from healthcare professionals. Patients will typically stay in a hospital for several days to several weeks, depending on the severity of their condition. This allows hospitals to provide the highest level of medical support and to help manage symptoms and/or side effects of the patients while they receive treatment.
Additional information:
The Neoplasm Treatments market comprises revenues and average revenue per capita. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.
In-Scope
- Inpatient treatment of cancer patients
Out-Of-Scope
- Long-term rehabilitative care
- Home-based rehabilitative care
